PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NA AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66685-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)66685-5/fulltext
Title :
PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NA AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66685-5&doi=10.1016/S1098-3015(10)66685-5
First page :
Section Title :
Open access? :
No
Section Order :
518